Concerted regulation of actin polymerization during constitutive secretion by cortactin and PKD2.


Journal

Journal of cell science
ISSN: 1477-9137
Titre abrégé: J Cell Sci
Pays: England
ID NLM: 0052457

Informations de publication

Date de publication:
13 12 2019
Historique:
received: 26 03 2019
accepted: 07 11 2019
pubmed: 16 11 2019
medline: 21 7 2020
entrez: 16 11 2019
Statut: epublish

Résumé

Constitutive secretion from the trans-Golgi-network (TGN) is facilitated by a concerted regulation of vesicle biogenesis and fission processes. The protein kinase D family (PKD) has been previously described to enhance vesicle fission by modifying the lipid environment. PKD also phosphorylates the actin regulatory protein cortactin at S298 to impair synergistic actin polymerization. We here report additional functions for PKD2 (also known as PRKD2) and cortactin in the regulation of actin polymerization during the fission of transport carriers from the TGN. Phosphorylation of cortactin at S298 impairs the interaction between WIP (also known as WIPF1) and cortactin. WIP stabilizes the autoinhibited conformation of N-WASP (also known as WASL). This leads to an inhibition of synergistic Arp2/3-complex-dependent actin polymerization at the TGN. PKD2 activity at the TGN is controlled by active CDC42-GTP which directly activates N-WASP, inhibits PKD2 and shifts the balance to non-S298-phosphorylated cortactin, which can in turn sequester WIP from N-WASP. Consequently, synergistic actin polymerization at the TGN and constitutive secretion are enhanced.

Identifiants

pubmed: 31727638
pii: jcs.232355
doi: 10.1242/jcs.232355
pii:
doi:

Substances chimiques

Actins 0
CID2950007 0
Cortactin 0
Pyrazoles 0
Sulfonamides 0
TRPP Cation Channels 0
polycystic kidney disease 2 protein 0
cdc42 GTP-Binding Protein EC 3.6.5.2

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2019. Published by The Company of Biologists Ltd.

Déclaration de conflit d'intérêts

Competing interestsThe authors declare no competing or financial interests.

Auteurs

Florian Weeber (F)

Department of Internal Medicine I, Ulm University, Albert-Einstein-Allee 23, D-89081 Ulm, Germany.

Alexander Becher (A)

Department of Internal Medicine I, Ulm University, Albert-Einstein-Allee 23, D-89081 Ulm, Germany.

Tanja Seibold (T)

Department of Internal Medicine I, Ulm University, Albert-Einstein-Allee 23, D-89081 Ulm, Germany.

Thomas Seufferlein (T)

Department of Internal Medicine I, Ulm University, Albert-Einstein-Allee 23, D-89081 Ulm, Germany.

Tim Eiseler (T)

Department of Internal Medicine I, Ulm University, Albert-Einstein-Allee 23, D-89081 Ulm, Germany tim.eiseler@uniklinik-ulm.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH